Skip to main content
. 2017 Mar 15;56(6):701–706. doi: 10.2169/internalmedicine.56.7722

Figure 2.

Figure 2.

Clinical course of the patient. Forty-five days after ATG initiation, the serum LDH level was elevated to more than 3,000 U/L, and the serum EBV-DNA level increased to 1.1×106 copies/106 cells. Following rituximab therapy, these levels rapidly decreased. Rituximab was administered once a week for 8 weeks.

HHS Vulnerability Disclosure